-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

Benzinga·08/03/2026 18:33:17
语音播报
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.